Selected Publications
ZMB Publications
Selected Publications
The list provides selected publications of the ZMB from 2004 to 2021, published in the journals listed below.
You can narrow the list down by year and author. If an error accured or no data was found, please reload or reset the page.
(View all ZMB publications via the interface of the university bibliography).
Journals
- ACS Nano
- Acta Neuropathologica
- Advanced Drug Delivery Reviews
- All Nature Journals
- American Journal of Human Genetics
- Angewandte Chemie International Edition
- Annals of Oncology
- Annual Review of Biochemistry
- Annual Review of Genetics
- Annual Review of Microbiology
- Biomaterials
- Biotechnology Advances
- Blood
- Brain
- Cancer Cell
- Cancer Discovery
- Cancer Research
- Cell
- Cell Clinical Cancer Research
- Cell Reports
- Chemical Reviews
- Chemical Society Reviews
- Circulation
- Circulation Research
- Current Biology
- eLife
- EMBO Molecular Medicine
- EMBO Reports
- Endocrine Reviews
- European Heart Journal
- FEMS Microbiology Reviews
- Gastroenterology
- Genes and Development
- Gut
- Hepatology
- Immunity
- Immunological Reviews
- JAMA: Journal of the American Medical Association
- JAMA Oncology
- JAMA Neurology
- Journal of Hepatology
- Journal of the American Chemical Society
- Journal of the American Medical Association
- Journal of Clinical Oncology
- Journal of Hepatology
- Lancet
- Leukemia
- Molecular Cell
- Molecular Psychiatry
- Natural Product Research
- Nature
- Nature Biotechnology
- Nature Chemical Biology
- Nature Communications
- Nature Genetics
- Nature Medicine
- Nature Methods
- Nature Nanotechnology
- Nature Reviews Molecular Cell Biology
- Nature Reviews Neurology
- Nature Structural & Molecular Biology
- Neuro-Oncology
- Nucleic Acids Research
- Proceedings of the National Academy of Sciences of the United States of America Science
- Science
- Science Advances
- The British Journal of Cancer
- The EMBO Journal
- The Journal of Cell Biology
- The Lancet
- The Lancet Diabetes and Endocrinology
- The Lancet Gastroenterology & Hepatology
- The Lancet Infectious Diseases
- The Lancet Neurology
- The Lancet Oncology
- The New England Journal of Medicine
- Trends in Neurosciences
- Trends in Pharmacological Sciences
There were 999 publications found
-
Ripretinib versus sunitinib in gastrointestinal stromal tumor : ctDNA biomarker analysis of the phase 3 INTRIGUE trialIn: Nature Medicine (2024) in pressOnline Full Text: dx.doi.org/ (Open Access)
-
A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanomaIn: Cell Vol. 187 (2024) Nr. 1, pp. 166 - 183.e25Online Full Text: dx.doi.org/ (Open Access)
-
Avapritinib-based SAR studies unveil a binding pocket in KIT and PDGFRAIn: Nature Communications Vol. 15 (2024) Nr. 1, 63Online Full Text: dx.doi.org/ (Open Access)
-
XPO1-Mediated mRNA Export of Genome Maintenance Regulators Drives Chemotherapy Resistance in Aggressive LymphomaIn: Cancer Research Vol. 84 (2024) Nr. 1, pp. 3 - 5Online Full Text: dx.doi.org/
-
Evolutionary trajectories of small cell lung cancer under therapyIn: Nature (2024) in pressOnline Full Text: dx.doi.org/ (Open Access)
-
VCF1 is a p97/VCP cofactor promoting recognition of ubiquitylated p97-UFD1-NPL4 substratesIn: Nature Communications Vol. 15 (2024) Nr. 1, 2459Online Full Text: dx.doi.org/ (Open Access)
-
Günter Wulff (1935 –2023) : Father of Molecular ImprintingIn: Angewandte Chemie International Edition (2024) e202402244 in pressOnline Full Text: dx.doi.org/ (Open Access)
-
Correction to: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identificationIn: Nature Communications Vol. 15 (2024) Nr. 1, 2364Online Full Text: dx.doi.org/ (Open Access)
-
Alteration of LARGE1 abundance in patients and a mouse model of 5q-associated spinal muscular atrophyIn: Acta Neuropathologica Vol. 147 (2024) Nr. 1, 53Online Full Text: dx.doi.org/ (Open Access)
-
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNAIn: Blood Vol. 143 (2024) Nr. 6, pp. 522 - 534Online Full Text: dx.doi.org/
-
Lysosomal damage sensing and lysophagy initiation by SPG20-ITCHIn: Molecular Cell (2024) in pressOnline Full Text: dx.doi.org/ (Open Access)
-
Thirty years of structural changesIn: Nature Structural & Molecular Biology (2024) in pressOnline Full Text: dx.doi.org/
-
Structure of the human KMN complex and implications for regulation of its assemblyIn: Nature Structural & Molecular Biology (2024) in pressOnline Full Text: dx.doi.org/ (Open Access)
-
TopBP1 utilises a bipartite GINS binding mode to support genome replicationIn: Nature Communications Vol. 15 (2024) Nr. 1, 1797Online Full Text: dx.doi.org/; Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction: Human CEACAM1 is targeted by a Streptococcus pyogenes adhesin implicated in puerperal sepsis pathogenesisIn: Nature Communications Vol. 14 (2023) Nr. 1, pp. 2675Online Full Text: dx.doi.org/ (Open Access)
-
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma : An international collaborative analysisIn: Leukemia Vol. 37 (2023) Nr. 7, pp. 1511 - 1520Online Full Text: dx.doi.org/ (Open Access)
-
Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapyIn: Blood Vol. 142 (2023) Nr. 25, pp. 2175 - 2191Online Full Text: dx.doi.org/ (Open Access)
-
Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotypeIn: Gut Vol. 72 (2023) Nr. 3, pp. 522 - 534Online Full Text: dx.doi.org/ (Open Access)
-
The structural flexibility of MAD1 facilitates the assembly of the Mitotic Checkpoint ComplexIn: Nature Communications Vol. 14 (2023) Nr. 1, 1529Online Full Text: dx.doi.org/ (Open Access)
-
Author Correction: Pan-cancer analysis of whole genomesIn: Nature Vol. 614 (2023) Nr. 7948, pp. E39Online Full Text: dx.doi.org/ (Open Access)
-
Immunotherapy targeting plasma ASM is protective in a mouse model of Alzheimer’s diseaseIn: Nature Communications Vol. 14 (2023) Nr. 1, 1631Online Full Text: dx.doi.org/ (Open Access)
-
Decrypting drug actions and protein modifications by dose- and time-resolved proteomicsIn: Science Vol. 380 (2023) Nr. 6640, pp. 93 - 101Online Full Text: dx.doi.org/
-
Circulating tumor DNA analysis of the phase III VOYAGER trial : KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenibIn: Annals of Oncology Vol. 34 (2023) Nr. 7, pp. 615 - 625Online Full Text: dx.doi.org/
-
Coinhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer via readthrough transcriptionIn: Science Advances Vol. 9 (2023) Nr. 41, eadg5109Online Full Text: dx.doi.org/ (Open Access)
-
Structural basis of ubiquitin-independent PP1 complex disassembly by p97In: The EMBO Journal Vol. 42 (2023) Nr. 14, e113110Online Full Text: dx.doi.org/ (Open Access)
-
Rho GTPase activity crosstalk mediated by Arhgef11 and Arhgef12 coordinates cell protrusion-retraction cyclesIn: Nature Communications Vol. 14 (2023) Nr. 1, 8356Online Full Text: dx.doi.org/ (Open Access)
-
Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic CancerIn: The New England Journal of Medicine Vol. 388 (2023) Nr. 1, pp. 33 - 43Online Full Text: dx.doi.org/
-
Impact of bimetallic interface design on heat generation in plasmonic Au/Pd nanostructures studied by single-particle thermometryIn: Nature Communications Vol. 14 (2023) Nr. 1, 3813Online Full Text: dx.doi.org/ (Open Access)
-
Neoadjuvant immunotherapy for melanoma is now ready for clinical practiceIn: Nature Medicine Vol. 29 (2023) Nr. 6, pp. 1310 - 1312Online Full Text: dx.doi.org/
-
Stable kinetochore-microtubule attachment requires loop-dependent Ndc80-Ndc80 bindingIn: The EMBO Journal Vol. 42 (2023) Nr. 13, e112504Online Full Text: dx.doi.org/ (Open Access)
-
HLA class II loss and JAK1/2 deficiency coevolve in melanoma leading to CD4 T cell and IFNγ cross-resistanceIn: Clinical Cancer Research Vol. 29 (2023) Nr. 15, pp. 2894 - 2907Online Full Text: dx.doi.org/
-
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responsesIn: Immunity Vol. 56 (2023) Nr. 6, pp. 1341 - 1358.e11Online Full Text: dx.doi.org/ (Open Access)
-
Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infectionIn: Science Advances Vol. 9 (2023) Nr. 27, eadf8251Online Full Text: dx.doi.org/ (Open Access)
-
Structure of the peroxisomal Pex1/Pex6 ATPase complex bound to a substrateIn: Nature Communications Vol. 14 (2023) Nr. 1, 5942Online Full Text: dx.doi.org/ (Open Access)
-
Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patientsIn: Nature Communications Vol. 14 (2023) Nr. 1, 2835Online Full Text: dx.doi.org/ (Open Access)
-
The hypoxia-regulated ectonucleotidase CD73 is a host determinant of HIV latencyIn: Cell Reports Vol. 42 (2023) Nr. 11, 113285Online Full Text: dx.doi.org/ (Open Access)
-
Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophyIn: Acta Neuropathologica Vol. 145 (2023) Nr. 5, pp. 611 - 635Online Full Text: dx.doi.org/ (Open Access)
-
LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer GrowthIn: Clinical Cancer Research Vol. 29 (2023) Nr. 6, pp. 1137 - 1154Online Full Text: dx.doi.org/
-
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized TrialIn: Clinical Cancer Research Vol. 29 (2023) Nr. 17, pp. 3313 - 3319Online Full Text: dx.doi.org/ (Open Access)
-
Importance of broken geometric symmetry of single-atom Pt sites for efficient electrocatalysisIn: Nature Communications Vol. 14 (2023) Nr. 1, 3233Online Full Text: dx.doi.org/ (Open Access)
-
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancerIn: Nature Vol. 615 (2023) Nr. 7950, pp. 168 - 174Online Full Text: dx.doi.org/ (Open Access)
-
Resting natural killer cell homeostasis relies on tryptophan/NAD⁺ metabolism and HIF-1αIn: EMBO Reports (2023) e56156Online Full Text: dx.doi.org/ (Open Access)
-
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG¹²C mutation : a randomised, open-label, phase 3 trialIn: Lancet Vol. 401 (2023) Nr. 10378, pp. 733 - 746Online Full Text: dx.doi.org/
-
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomasIn: Cancer Cell Vol. 41 (2023) Nr. 1, pp. 210 - 225.e5Online Full Text: dx.doi.org/
-
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in GlioblastomaIn: Clinical Cancer Research Vol. 29 (2023) Nr. 2, pp. 488 - 500Online Full Text: dx.doi.org/ (Open Access)
-
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR) : An international, single-arm, phase 2 studyIn: The Lancet Oncology Vol. 24 (2023) Nr. 8, pp. 925 - 935Online Full Text: dx.doi.org/
-
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O) : disease-free survival results from a randomised, open-label, phase 2 trialIn: Lancet Vol. 402 (2023) Nr. 10404, pp. 798 - 808Online Full Text: dx.doi.org/
-
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytomaIn: Acta Neuropathologica Vol. 149 (2023) Nr. 4, pp. 551 - 564Online Full Text: dx.doi.org/ (Open Access)
-
Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomasIn: Neuro-Oncology Vol. 25 (2023) Nr. 9, pp. 1721 - 1723Online Full Text: dx.doi.org/ (Open Access)
-
Human CEACAM1 is targeted by a Streptococcus pyogenes adhesin implicated in puerperal sepsis pathogenesisIn: Nature Communications Vol. 14 (2023) Nr. 1, 2275Online Full Text: dx.doi.org/ (Open Access)